4//SEC Filing
Bair Teresa Brophy 4
Accession 0001209191-22-057874
CIK 0001422143other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:53 PM ET
Size
5.5 KB
Accession
0001209191-22-057874
Insider Transaction Report
Form 4
Bair Teresa Brophy
Chief Legal Officer
Transactions
- Sale
Common Stock
2022-11-17$15.22/sh−2,100$31,965→ 0 total
Footnotes (3)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2022.
- [F2]2,100 shares were acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $15.08 to $15.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001813058
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:53 PM ET
- Size
- 5.5 KB